Flourish Research logo “For 30 years, Diablo has built its reputation ... N.C., will acquire the Australian pharmaceutical company Mayne Pharma Group, which has its U.S. headquarters in Raleigh.

In a report released today, Shane Storey from Wilsons maintained a Buy rating on Telix Pharmaceuticals Ltd. (TLPPF – Research Report), with a ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on OrthoPediatrics (KIDS – Research Report) and ...

The Boards of Directors of both companies have approved the transaction and Mayne Pharma’s Board of Directors has unanimously recommended that its shareholders vote in favor of the transaction.

Mayne Pharma sells products in Australia and the US for birth control and menopause treatments, including its Nextstellis contraceptive pill. Shutterstock Mayne’s shareholders include Viburnum ...

Cosette Pharmaceuticals Inc, which is backed by Avista Healthcare Partners and Hamilton Lane, has agreed to acquire Mayne Pharma, an Australian specialty pharmaceutical company, for $430 million.

Pubs baron Bruce Mathieson, a major investor in Mayne Pharma, is backing a $672m takeover offer for the drugs maker by US giant Cosette. Mayne told shareholders that in the absence of a better ...

The Boards of Directors of both companies have approved the transaction and Mayne Pharma’s Board of Directors has unanimously recom Mayne Pharma Group Limited (Mayne Pharma or the Company ...

Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe ...